May 22, 2018
Category: General
Posted by: normp2018

Submitted abstracts are now published in Basic and Clinical Pharmacology and Toxicology.

The published supplement can be found at:

Mar 26, 2018
Category: General
Posted by: normp2018

To accommodate any unforeseen circumstances during Easter, we have decided to extend the early bird deadline until April 3rd 12.00 CET (noon).

Mar 9, 2018
Category: General
Posted by: normp2018

We've updated the sponsor prospect with new reduced prices. Please do not hesitate to contact organiser Tore B. Stage ( with any questions.

Feb 16, 2018
Category: General
Posted by: normp2018

Abstract deadline has been extended until 11.59 PM CET March 15th 2018.

Nov 20, 2017
Category: General
Posted by: normp2018

We're happy to announce registration is now open for the conference. Link and prices can be found under "Practical information and registration". 

Sep 22, 2017
Category: General
Posted by: normp2018

Abstracts can now be submitted to this conference. The deadline is February 15th 2018 11.59 PM CET.

Jun 9, 2017
Category: General
Posted by: normp2018

The session titles and chairs have been added to the section for the scientific program. Invitations are currently being sent for invited speakers and we hope to be able to finalize the scientific program soon. 

Oct 31, 2016
Category: General
Posted by: admin

The website is now up and running! Stay tuned for more information regarding this conference.


Full program (including time schedule) available here: Program.

Speakers and sessions are listed below.


Keynote speakers

Ewan Pearson, Dundee University - Pharmacogenetics of glucose-lowering drugs

Alex Sparreboom, Ohio University - The role of drug transporters in chemotherapy-induced toxicity


Plenary sessions (chairs) and confirmed speakers

Novel methods for assessing drug toxicity (Tore B. Stage):

  • Deanna L. Kroetz, UCSF - iPSC-derived sensory neurons to assess chemotherapy-induced sensory neuropathies
  • Magnus Ingelman-Sundberg, Karolinska Institutet - Novel in vitro systems for better prediction of drug metabolism and hepatotoxicity

Pharmacoepigenetics and biomarkers (Ingolf Cascorbi and Magnus Ingelman-Sundberg):

  • Ingolf Cascorbi, University of Kiel - miRNAs as mediators of drug resistance
  • Pascale Fisel, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Stuttgart and University of Tuebingen, Germany - DNA Methylation of ADME Genes: Clinical implications
  • Carmen Jerónimo, University of Porto - Diagnostic and prognostic epigenetic biomarkers in cancer.

Drug transporters (Mikko Niemi)

  • Niels Jessen, Aarhus University - Assessing OCT-function in vivo using 11C-labeled metformin
  • Mikko Niemi, University of Helsinki - Pharmacogenomics of transporters; OATP1B1, BCRP, rare variants

Personalised medicine in oncology - success stories from the real World

  • Kjeld Schmiegelow, Copenhagen University Hospital - Phenotyping and genotyping in childhood leukemia - precision medicine in an international setting


Parallel session titles (chairs)

Personalized medicine: Cardiovascular disease (Niels Jessen)

  • Lars M. Rasmussen, Odense University Hospital - Protein biomarkers for cardiovascular conditions - perspectives for personalized medicine?
  • Henning Bundgaard, Copenhagen University Hospital - Inherited cardiac diseases and personalized medicine

Next generation sequencing and rare variants in personalized medicine (Magnus Ingelman-Sundberg)

  • Volker Lauschke, Karolinska Institutet - Integrating rare genetic variability into preemptive pharmacogenomic advice
  • Matthias Schwab, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Stuttgart and University of Tuebingen, Germany - Twin studies and systems pharmacology as innovative tools for clinical pharmacokinetics

Role of the gut microbiome in ADME (Troels K. Bergmann and Mette Marie Christensen)

  • Nikunjkumar Patel, Certara - State of the art PBPK modelling of the metabolism and back conversion of compounds within the gastrointestinal tract
  • Oliver Hatley, Certara - Gut wall metabolism

Pharmacogenetics and adverse drug reactions (Per Damkier)

  • Henk-Jan Guchelaar, Leiden University Medical Center - Challenges to the clinical utility of PGx in the prevention of adverse drug reactions
  • Munir Pirmohamed, University of Liverpool - Advances in PGx of adverse drug reactions
  • Ann Daly, University of Newcastle - The genetic basis of drug-induced liver injury

New aspects of P450 variability (Janne Backman)

  • Andrea Gaedigk, Children's Mercy Kansas City - CYP2D6 pharmacogenetics: from a scientific cornucopia towards routine clinical practice
  • Kim Brøsen, University of Southern Denmark - Clinical significance of cytochrome P450 mediated drug interactions 
  • Gerd Mikus, Heidelberg University Hospital - Cytochrome P450 phenotyping and the microdosing approach

Using big data to develop personalized medicine (Kim Brøsen and Henrik Berg Rasmussen)

  • Jens Lundgren, University of Copenhagen - Personalized Medicine and big data in Immune Deficiency
  • Søren Brunak, University of Copenhagen - Analyzing drug response data from medical records
  • Christiane Gasse, Aarhus University - Danish National Health Registries and Pharmacogenetics in Psychiatry